Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Canopy Growth Is Intriguing If You Can Get Over the Credibility Issue

After so many misses, Canopy Growth stock suffers from a credibility drain. Nevertheless, political and medicinal shifts present an interesting contrarian case for CGC.

The Good, Bad, and Ugly for Energy Transfer

A few weeks was all it took to deflate the comeback narrative for ET stock. Here are the factors that could play a big role in where Energy Transfer goes from here.

How the U.S. Constitution Is Helping Inovio Pharmaceuticals

INO stock has transformed this year from unknown to a Wall Street darling. But with a worsening pandemic, the long-term case for Inovio has become even more credible.

Bank of America Is a Q2 Earnings Story to Avoid

Just a few days ago, optimism reigned for BAC stock on positive coronavirus news. But now, that narrative has changed for the worse.

Royal Caribbean May See a Quick Lift Off Positive Industry News

In the near term, positive industry news bodes well for RCL stock. But if you have a longer-term horizon, I wouldn’t be too quick to book a trip with Royal Caribbean.